GLP-1 Shot Tracker: OneShot
GLP-1 Shot Tracker: OneShot is a medication adherence and health tracking tool for patients on GLP-1 therapies, available on iOS.
The App DNA
What makes this app unique?
The app removes the cognitive burden of tracking complex, multi-week titration schedules and injection site rotation for chronic medication users.
For Individuals prescribed GLP-1 medications like Zepbound, Mounjaro, Wegovy, or Ozempic who require structured tracking for weight loss or diabetes management.
What does it look like?
Key features
Generates reports correlating shot timing, weight, side effects, and nutrition data for GLP-1 users.
Tracks injection locations across twelve body zones to prevent skin reactions.
Calculates calories and macros via photo capture, barcode scanning, or voice input.
How much does it cost?
The app is currently free to download with no explicit subscription or IAP tiers mentioned in the store metadata.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
The app currently operates on a maintenance cadence, having shipped only one release in the observed window. Development is focused on UX improvements and stability, specifically refining the core tracking functionality. There is no evidence of a high-frequency release cycle or live-ops strategy. Future updates are expected to continue at this infrequent pace based on current activity.
Who built it?
OYE TEKNOLOJI ANONIM SIRKETI
9 apps tracked · Health & Fitness
TalkieCat: Cat Translator
SunSafe Tanning : Sun Tracker
MeowTalk : Cat Translator AI
Stud Finder Wall Wood Detector
Faceless Video・Reels & Shorts
Metal Detector : Gold Finder
Baby Prediction App:Predictor
Deen Buddy: Halal Food ScannerUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for GLP-1 Shot Tracker: OneShot
How's the Health & Fitness market?
GLP-1 Shot Tracker: OneShot occupies a specialized niche in the Health & Fitness category, currently holding a 4.2-star rating. The lack of a clear monetization model distinguishes it from broader health trackers that gate advanced features behind subscriptions.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for GLP-1 Shot Tracker: OneShot
Where is it heading?
The GLP-1 management market is consolidating, and GLP-1 Shot Tracker: OneShot remains in a stable but vulnerable position. Without a clear monetization strategy, the app risks being absorbed by generalist trackers that can scale faster.
- The app maintains a maintenance-mode release cadence, which limits its ability to respond to market shifts in the GLP-1 space.
The SWOT
- Injection site rotation mechanism prevents skin reactions
- Weekly AI insights provide personalized feedback
- Localized titration guides for international markets
Next best moves
Implement a premium subscription tier because the current free-only model lacks a clear revenue path → secure long-term development funding.
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of monetization is not a…
Read the full takeBottom line
GLP-1 Shot Tracker: OneShot serves a critical need for medication adherence, but the lack of a monetization model threatens its long-term viability. Transitioning to a premium tier would secure the resources needed to defend the app against generalist health trackers.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated